NovaBay Pharmaceuticals, Inc.
NBY
$0.585
$0.000.00%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.59% | 3.33% | -58.80% | -37.65% | -15.78% |
| Total Receivables | -44.74% | 28.70% | -25.48% | 7.94% | -25.76% |
| Inventory | 53.61% | -28.86% | 4.95% | 33.13% | -86.03% |
| Prepaid Expenses | 4.32% | 14.91% | -40.59% | 5.86% | 56.10% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 36.21% | 23.40% | -2.08% | -96.56% | 3,575.00% |
| Total Current Assets | -15.09% | 1.15% | -37.26% | -49.80% | -12.90% |
|
|
|||||
| Total Current Assets | -15.09% | 1.15% | -37.26% | -49.80% | -12.90% |
| Net Property, Plant & Equipment | -8.61% | -7.78% | -7.21% | -6.80% | -14.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.03% | 3.99% | -0.21% | -4.02% | -0.80% |
| Total Assets | -11.71% | -1.22% | -26.73% | -40.70% | -29.71% |
|
|
|||||
| Total Accounts Payable | 57.32% | -67.94% | 10.56% | 23.29% | -4.33% |
| Total Accrued Expenses | 94.19% | -24.43% | 0.58% | -55.43% | 41.35% |
| Short-term Debt | 1,007.84% | -92.67% | -30.88% | -11.43% | -10.47% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.05% | 2.09% | 1.87% | 1.90% | -24.12% |
| Total Finance Division Other Current Liabilities | -35.02% | -2.85% | -14.49% | 29.51% | -33.01% |
| Total Other Current Liabilities | -35.02% | -2.85% | -14.49% | 29.51% | -33.01% |
| Total Current Liabilities | 43.30% | -45.04% | -8.00% | -8.27% | -6.41% |
|
|
|||||
| Total Current Liabilities | 43.30% | -45.04% | -8.00% | -8.27% | -6.41% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1,007.84% | -92.67% | -30.88% | -11.43% | -10.47% |
| Capital Leases | -13.64% | -11.91% | -10.47% | -6.05% | -10.93% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -30.54% | -- |
| Total Liabilities | 26.63% | -38.24% | -12.60% | -9.14% | -1.63% |
|
|
|||||
| Common Stock & APIC | 0.01% | 2.18% | 1.29% | 0.51% | 3.21% |
| Retained Earnings | -0.67% | -1.23% | -0.89% | -2.06% | -5.53% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -112.66% | 271.11% | 52.98% | -197.14% | -73.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | -99.60% | -23.85% | -1.37% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -99.60% | -23.85% | -1.37% |
|
|
|||||
| Total Common Equity | -112.66% | 271.11% | 52.98% | -197.14% | -73.04% |
| Total Preferred Equity | 0.00% | 0.00% | -99.60% | -23.85% | -1.37% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -112.03% | 273.74% | -485.63% | -95.17% | -52.91% |
|
|
|||||